We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Neoleukin Therapeutics, Inc's financial performance into perspective.
March 8, 2023
Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition
December 12, 2022
Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
November 14, 2022
August 10, 2022 at 1:00 PM EDT
August 9, 2022 at 4:30 PM EDT
More presentations coming soon.